genvoya® 150 mg/150 mg/200 mg/10 mg combination tablet
modern pharmaceutical company abu dhabi-khia9 - tenofovir, emtricitabine, cobicistat, elvitegravir - tablet - combination - infections-antiviral
vitekta
gilead sciences (nz) - elvitegravir 85mg; ; ; ; - film coated tablet - 85 mg - active: elvitegravir 85mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry green 85f91203 sodium laurilsulfate - indicated for the treatment of hiv-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.
stribild film coated tablet 150 mg150 mg200 mg245 mg
gilead sciences singapore pte. ltd. - cobicistat on silicon dioxide 288.5mg eqv cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate 300.0mg eqv tenofovir disoproxil - tablet, film coated - cobicistat on silicon dioxide 288.5mg eqv cobicistat 150.0mg; elvitegravir 150.0mg; emtricitabine 200.0mg; tenofovir disoproxil fumarate 300.0mg eqv tenofovir disoproxil 245.0 mg
evotaz tablet
bristol-myers squibb canada - atazanavir (atazanavir sulfate); cobicistat - tablet - 300mg; 150mg - atazanavir (atazanavir sulfate) 300mg; cobicistat 150mg - hiv protease inhibitors
evotaz 300mg150mg tablets
bristol-myers squibb pharmaceuticals ltd - atazanavir sulfate; cobicistat - tablet - 300mg ; 150mg
mycobutin capsule
pfizer canada ulc - rifabutin - capsule - 150mg - rifabutin 150mg - antituberculosis agents
tybost tablet
gilead sciences canada inc - cobicistat - tablet - 150mg - cobicistat 150mg - other miscellaneous therapeutic agents
celsentri tablet
viiv healthcare ulc - maraviroc - tablet - 150mg - maraviroc 150mg - hiv fusion inhibitors
celsentri maraviroc 150 mg tablets bottles
viiv healthcare pty ltd - maraviroc -
darunavir doc generici 150 mg, filmomhulde tabletten